<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01458457</url>
  </required_header>
  <id_info>
    <org_study_id>BBK</org_study_id>
    <nct_id>NCT01458457</nct_id>
  </id_info>
  <brief_title>Life Quality and Mental State in Patients With Breast Cancer</brief_title>
  <acronym>BBK</acronym>
  <official_title>Life Quality and Mental State in Patients With Breast Cancer - a Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda Sanitaria de Sudtirol, Hospital Meran, Meran, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized pragmatic trial to evaluate the comparative effectiveness regarding disease
      specific quality of life of an individualized additional complementary medicine treatment in
      addition to usual care with usual care only in 280 women with breast cancer
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional Assessment of Cancer Therapy-Breast quality of life instrument (FACT-B)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subscales of the Functional Assessment of Cancer Therapy - General (FACT-G): physical well-being, social/family well-being, emotional well-being, functional well-being)</measure>
    <time_frame>3, 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subscale for Breast Cancer of the Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)</measure>
    <time_frame>3, 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain, quality of sleep, and nausea (single items of the FACT-B)</measure>
    <time_frame>3, 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Assessment of Chronic Illness Therapy-Fatigue</measure>
    <time_frame>3, 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival without relapse</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (SF-12 Health Survey)</measure>
    <time_frame>3, 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Undesirable Effects and Interactions</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Goal Attainment Scale</measure>
    <time_frame>3 months</time_frame>
    <description>This outcome measures will only be assessed in the complementary medicine arm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Used complementary Therapies and their frequency</measure>
    <time_frame>6 months</time_frame>
    <description>This will only be assessed in the complementary medicine arm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expectations at Baseline</measure>
    <time_frame>Baseline</time_frame>
    <description>This will only be assessed in the complementary medicine group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction and patient-reported effectiveness</measure>
    <time_frame>3, 6 months</time_frame>
    <description>This will only be assessed in the complementary medicine arm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">275</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care + Complementary Medicine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Individualized complementary medicine treatment</intervention_name>
    <description>An individual treatment plan will be made for each patient that includes one to all of the following treatments: acupuncture, traditional Chinese herbal medicine, enzyme therapy, nutrition advise, Healing Touch, homoeopathy, hyperthermia treatment, infusions, laser therapy, lymphatic drainage, manual therapy, mistel therapy, neural therapy, orthomolecular therapy, osteopathy, phytotherapy, shiatsu</description>
    <arm_group_label>Usual Care + Complementary Medicine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Individualized usual care</intervention_name>
    <description>Patients get usual care from their general practitioners/specialized physicians</description>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_label>Usual Care + Complementary Medicine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosed breast cancer

          -  current usual care treatment

          -  willing to refrain from complementary treatment for 6 months in case of randomization
             into the usual care group

          -  informed consent

        Exclusion Criteria:

          -  complementary treatment at the Hospital Meran in the last 6 months

          -  no German or Italian language ability

          -  participation in other study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudia M Witt, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Meran Hospital - Dienst fuer Komplementaermedizin</name>
      <address>
        <city>Meran</city>
        <zip>39012</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Witt CM, Außerer O, Baier S, Heidegger H, Icke K, Mayr O, Mitterer M, Roll S, Spizzo G, Scherer A, Thuile C, Wieser A, Schützler L. Effectiveness of an additional individualized multi-component complementary medicine treatment on health-related quality of life in breast cancer patients: a pragmatic randomized trial. Breast Cancer Res Treat. 2015 Jan;149(2):449-60. doi: 10.1007/s10549-014-3249-3. Epub 2015 Jan 3.</citation>
    <PMID>25555830</PMID>
  </results_reference>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2011</study_first_submitted>
  <study_first_submitted_qc>October 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 24, 2011</study_first_posted>
  <last_update_submitted>February 13, 2015</last_update_submitted>
  <last_update_submitted_qc>February 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Claudia M. Witt</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

